AdvaMed, the world’s largest medical technology trade association, is calling on the US Food and Drug Administration (FDA) to leverage its existing regulatory framework for generative AI (GenAI)-enabled medical devices when assessing for risk and safety, rather than building an entirely new framework.
The recommendation is one of several the